STOCK TITAN

Janus Henderson (ADAG) reports 6.67M ADRs, 10.1% stake (04/30/2026)

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Adagene Inc. ownership disclosure: Janus Henderson Group plc reports beneficial ownership of 6,666,666 American Depository Receipts, representing 10.1% of the class as of 04/30/2026. The Asset Managers exercise shared voting and dispositive power over those ADRs on behalf of managed portfolios.

The filing states the Asset Managers generally exercise investment and voting discretion for client accounts and that only the Janus Henderson Biotech Innovation Master Fund Ltd. holds more than 5% of the ADRs among the managed portfolios. Signature dated 05/07/2026.

Positive

  • None.

Negative

  • None.

Insights

Large passive stake reported by Janus Henderson; voting power is shared across managers.

Janus Henderson Group plc is reported as the ultimate parent of multiple SEC‑registered asset managers that together may be deemed beneficial owners of 6,666,666 ADRs (the filing labels this as 10.1% of the class as of 04/30/2026). The filing attributes shared voting and dispositive power to the Asset Managers rather than sole control.

Key dependencies include which specific managed portfolios hold the ADRs and the irrevocable delegation noted for certain funds. Subsequent filings or exhibits (Item 7/Exhibit 99) identify the acquiring subsidiary and should be reviewed for allocation details.

Disclosure indicates standard institutional custody/management structure, not direct dividend/proceeds rights by the parent.

The Asset Managers state they exercise investment/voting discretion for client accounts while disclaiming rights to receive dividends or sale proceeds directly; managed portfolios retain those economic rights. The filing highlights that only one fund among the managed portfolios exceeds a 5% economic interest threshold.

Watch Exhibit 99 and the power‑of‑attorney exhibit for details on which subsidiary executed the acquisition and for any future Section 13 filings that change percent ownership.

Beneficial ownership 6,666,666 ADRs Amount reported as beneficially owned
Percent of class 10.1% Percent of ADR class as reported
Reporting date 04/30/2026 Ownership as of date
Signature date 05/07/2026 Schedule signed by Head of North America Compliance
Sole voting power 0 shares Sole voting power reported
Shared voting/dispositive power 6,666,666 shares Shared voting and disposal power reported
CUSIP 005329107 ADAG American Depository Receipt CUSIP
American Depository Receipt financial
"Title/Item 2(d) states Title of class of securities: American Depository Receipt"
An American Depositary Receipt (ADR) is a certificate issued by a U.S. bank that represents ownership of shares in a foreign company and lets those shares trade on U.S. exchanges in U.S. dollars. For investors, ADRs remove many barriers to buying foreign stocks—handling currency conversion, settlement and some reporting—so holding an ADR is like using a local adapter that makes a foreign security behave more like a domestic one, improving access and liquidity.
Beneficial owner regulatory
"Item 4 describes the Asset Managers may be deemed the beneficial owner"
A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.
Managed Portfolios financial
"Item 4 references Managed Portfolios as client accounts controlled by Asset Managers"
Investment Company Act of 1940 regulatory
"Item 6 references shareholders of an investment company registered under the Investment Company Act of 1940"
A U.S. federal law that sets the rulebook for pooled investment vehicles such as mutual funds, exchange-traded funds and similar money managers, requiring them to register with regulators, disclose holdings and fees, limit conflicts of interest, and follow governance standards. It matters to investors because these protections and transparency rules act like a referee and scoreboard, helping people compare funds, trust that managers follow fair practices, and spot hidden costs or risks.





005329107

(CUSIP Number)
04/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G



JANUS HENDERSON GROUP PLC
Signature:Kristin Mariani
Name/Title:Head of North America Compliance
Date:05/07/2026
Exhibit Information

Exhibit 24: Power of Attorney Exhibit 99: Item 7

FAQ

What stake does Janus Henderson report in ADAG (Adagene Inc.)?

Janus Henderson reports beneficial ownership of 6,666,666 ADRs, equal to 10.1% of the class as of 04/30/2026. The figure reflects positions held across multiple managed portfolios where asset managers exercise voting discretion.

Does Janus Henderson have sole voting or dispositive power over ADAG ADRs?

No. The filing states Janus Henderson has 0 shares of sole voting power and 6,666,666 shares of shared voting and dispositive power, indicating shared control among its asset managers.

Which fund holds more than 5% of ADAG ADRs within Janus Henderson's portfolios?

The filing identifies the Janus Henderson Biotech Innovation Master Fund Ltd. as the only managed portfolio with the right to receive dividends or proceeds for more than 5% of the ADRs reported in this schedule.

What dates are relevant in this Schedule 13G filing for ADAG?

The ownership is reported as of 04/30/2026 and the filing bears a signature date of 05/07/2026. Exhibit references (Exhibit 99 and Exhibit 24) provide subsidiary and power‑of‑attorney details.

Do the Asset Managers receive dividends or sale proceeds for these ADAG ADRs?

The filing states the Managed Portfolios have the right to receive dividends and sale proceeds; the Asset Managers exercise voting/dispositive discretion but disclaim rights to directly receive dividends or proceeds.